These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7518121)

  • 1. Protection from complement-mediated cytolysis in cross-species hepatocytes transfected with complement regulatory factor (HRF20) using retroviral vector.
    Hayashi S; Isobe K; Emi N; Kasai Y; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1252. PubMed ID: 7518121
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of species-specific complement-mediated cytolysis in xenoendothelial cells transfected with GPI-anchored complement regulatory factor (DAF, HRF20) gene using retroviral vector: comparison between single (DAF or HRF20) and double (DAF and HRF20) transfected xenoendothelial cells.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1243-4. PubMed ID: 7518119
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.
    Hayashi S; Isobe K; Emi N; Okada H; Yasutomi M; Negita M; Koike C; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Feb; 27(1):330. PubMed ID: 7533402
    [No Abstract]   [Full Text] [Related]  

  • 4. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404
    [No Abstract]   [Full Text] [Related]  

  • 5. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
    Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
    Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells.
    Kooyman D; Byrne G; McClellan S; Nielsen D; Kagan D; Coffman T; Masahide T; Waldmann H; Platt J; Logan J
    Transplant Proc; 1994 Jun; 26(3):1241. PubMed ID: 7518117
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction and expression of human CD59 gene in the canine kidney.
    Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Tomita N; Kaneda Y; Tanaka K
    Transplant Proc; 1994 Jun; 26(3):1315-7. PubMed ID: 7518127
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of human DAF and MCP on pig endothelial cells protects from human complement.
    Carrington CA; Richards AC; Cozzi E; Langford G; Yannoutsos N; White DJ
    Transplant Proc; 1995 Feb; 27(1):321-3. PubMed ID: 7533398
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
    Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
    Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of MLV vector particles from human complement.
    Breun S; Salmons B; Günzburg WH; Baumann JG
    Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of complement-resistant retroviral vector by homologous restriction factor 20 gene.
    Hayashi S; Emi N; Okada H; Nagasaka T; Yokoyama I; Takagi H
    Gene Ther; 1998 Feb; 5(2):282-5. PubMed ID: 9578850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
    Xu L; Shao H; Wu W; Cao Z; Zhao Z; Liu H; Jiang D; Mao X; Li W
    Int J Mol Med; 2005 Sep; 16(3):409-14. PubMed ID: 16077947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice.
    Diamond LE; Oldham ER; Platt JL; Waldmann H; Tone M; Walsh LA; Logan JS
    Transplant Proc; 1994 Jun; 26(3):1239. PubMed ID: 7518115
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of xeno-hepatocytes from complement-mediated cytolysis by transduction with homologous restriction factor 20 gene using retroviral vector.
    Hayashi S; Isobe K; Emi N; Okada H; Yokoyama I; Takagi H
    Eur Surg Res; 1998; 30(3):161-7. PubMed ID: 9627212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.
    Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
    Eur J Immunol; 1993 Oct; 23(10):2714-6. PubMed ID: 7691615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
    Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.